Parks, who inspired them as young scientists
Once approved, here is what the pricing landscape looks like based on comparable drugs: Semaglutide (Wegovy) without insurance runs $1,300 to $1,600 per month in the US Tirzepatide (Zepbound) without insurance runs $1,000 to $1,300 per month in the US Retatrutide, as a next-generation triple agonist, will likely land at $1,200 to $1,800 per month at launch In Australia, the UK, and Canada, prices tend to be lower due to government drug pricing controls
Lyophilized (unmixed) powder should also be refrigerated for short-term storage within a 3-6 month window, or kept frozen at -20C or below for longer durations
There was an option to upload blood work but it was not required
Promising, but preliminary Phytogene is still in the early stages of development